http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c69eebb2f0bcc494f5106f6bd27fb7a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gown |
| name | Allen M. Gown Allen M Gown |
| given-name | Allen M. Allen M |
| organization-name | Chun Hing Tse, Harry C. Hwang, Lynn C. Goldstein, Patricia L. Kandalaft, Steven J. Kussick, and Allen M. Gown, PhenoPath Laboratories; Jesse C. Wiley and Steven J. Kussick, University of Washington, Seattle, WA; Allen M. Gown, University of British Columbia, Vancouver, British Columbia, Canada. Division of Medical Genetics, Box 357720, Department of Medicine, Departments of Pathology, Pediatrics, Biochemistry, and Immunology, University of Washington, Seattle, WA 98195; and Bristol–Myers Squibb Pharmaceuticals, Seattle, WA 98121 Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada (Gown) Departments of Physiology and Biophysics and Pathology, University of Washington, Seattle, Washington, and Department of Biochemistry, Johns Hopkins University, Baltimore, Maryland PhenoPath Laboratories Seattle WA USA Seattle, Washington From the Henry Ford Hospital, Detroit, Mich (Drs Zarbo, Prasad, and Savera); University of California at San Francisco (Dr Regezi); and PhenoPath Laboratories, Seattle, Wash (Dr Gown). From the University of California, San Francisco, San Francisco; Genomic Health, Redwood City; Kaiser Permanente, Oakland, CA; and PhenoPath Laboratories, Seattle, WA. 2Phenopath Laboratories, Seattle, Washington; and From the Division of Medical Oncology, Breast Cancer Outcomes Unit, and Division of Radiation Oncology, British Columbia Cancer Agency; Genetic Pathology Evaluation Centre and Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; and PhenoPath Laboratories, Seattle, WA From the Henry Ford Hospital, Detroit, Mich (Drs Prasad, Savera, and Zarbo), and PhenoPath Laboratories, Seattle, Wash (Dr Gown). 1PhenoPath Laboratories, PLLC, Seattle, WA PhenoPath Laboratories and IRIS, Seattle, WA From the Genetic Pathology Evaluation Centre at Vancouver General Hospital, Prostate Centre, and University of British Columbia; Breast Cancer Outcomes Unit and Population and Preventive Oncology Programs at BC Cancer Agency, Vancouver, British Columbia, Canada; and PhenoPath Laboratories, Seattle, WA Departments of Pathology (H-AL, AMG) and Radiology (DAM), University of Washington, Seattle, Washington; Dynacare Laboratory of Pathology (DC), Seattle, Washington; and Cattedra di Anatomia Patologica (GS), II Universita' di Roma, “Tor Vergata,” Rome, Italy. Departments of Pathology, University of Washington, Seattle, Washington, and Shaughnessy Hospital and University of British Columbia, Vancouver, British Columbia, Canada From the Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; and PhenoPath Laboratories and IRIS, Seattle, WA. PhenoPath Laboratories, University of British Columbia, Vancouver, BC PhenoPath Laboratories and Immunocytochemical Research Institute of Seattle, Seattle, Washington PhenoPath Laboratories, Seattle, WA. From PhenoPath Laboratories, Seattle, Washington; and the Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada. Department of Pathology, University of Washington, Seattle 98195. PhenoPath Laboratories and IRIS, Seattle, Washington Instituto di Anatomia Patologica. Universitá di Verona, Italy, and the Department of Pathology, University of Washington, Seattle, Washington. From the Department of University of Washington, Seattle, Washington From the Henry Ford Hospital, Detroit, Mich (Drs Stone, Lee, and Zarbo); Emory University School of Medicine, Atlanta, Ga (Dr Amin); PhenoPath Laboratories, Seattle, Wash (Drs Yaziji and Gown); University of Texas M. D. Anderson Cancer Center, Houston, Tex (Dr Ro); L'Hôtel-Dieu de Québec, Québec, Canada (Dr Têtu); and CHRU Dupuytren, Limoges, France (Dr Paraf). Department of Pathology, University of Washington, Seattle, Washington From the Department of Pathology, University of Chicago, Chicago, Illinois (Drs Husain and Krausz); the Department of Pathology, Mayo Clinic College of Medicine, Scottsdale, Arizona (Dr Colby); the Section of Immunocytochemistry, Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston (Dr Ordóñez); the Department of Pathology, Columbia University Medical Center, New University of British Columbia, Vancouver, BC (AMG) Department of Immunohistochemistry and Anatomic Services, Pacific Pathology Partners, Seattle, Washington (Dr Kandalaft); PhenoPath Laboratories, Seattle (Dr Gown); and Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada (Dr Gown). 10PhenoPath Laboratories, Seattle, Washington From the Departments of Pathology, Veteran Affairs and University of California Medical Center, San Francisco (Drs Kakar and Ferrell); PhenoPath Laboratories, Seattle, Wash (Dr Gown); and the Division of Hepatic Pathology, Armed Forces Institute of Pathology, Washington, DC (Dr Goodman) PhenoPath Laboratories, Seattle, WA Department of Pathology and Research Center in Oral BiologyUniversity of WashingtonSeattleWashington98195USA University of New York at Stony Brook School of Medicine, Stony Brook, New York; University of Washington School of Medicine, Seattle, Washington; Scripps Clinic and Research Foundation, La Jolla and City of Hope National Medical Center, Duarte, California; The University of Connecticut Health Center, Farmington, Connecticut; Sinai Hospital of Detroit, Detroit, Michigan; National Institutes of He The PhenoPath Laboratories PLLC Phenopath Laboratories and Immunocytochemical Research Institute, Seattle, WA Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (BSS, SEK, SZ, SY); PhenoPath Laboratories, Seattle, Washington (RF, CJ, AMG); Trev and Joyce Deeley Research Centre (KM, BHN), BC Cancer Agency, Vancouver, British Columbia, Canada; Division of Medical Oncology (GG, JL, CH), BC Cancer Agency, Vancouver, British Columbia, Canada; Canada’s Michael Smith Genome Sciences Centre (MJ, EZ, EP, SJMJ, MAM), BC Cancer Agency, Vancouver, British Columbia, Canada |
Incoming Links
Total number of triples: 228.